Serum brain derived neurotrophic factor levels and post-stroke depression in ischemic stroke patients

Xinyue Chang,Yu He,Yi Liu,Jiawen Fei,Xiaoli Qin,Beiping Song,Quan Yu,Mengyao Shi,Daoxia Guo,Li Hui,Jing Chen,Aili Wang,Tan Xu,Jiang He,Yonghong Zhang,Zhengbao Zhu
DOI: https://doi.org/10.1016/j.jad.2024.06.050
IF: 6.533
2024-06-20
Journal of Affective Disorders
Abstract:Background Brain-derived neurotrophic factor (BDNF) is crucial for neuronal survival and may be implicated in the pathophysiological process of depression. This study aimed to prospectively investigate the association between serum BDNF and post-stroke depression (PSD) at 3 months in a multicenter cohort study. Methods A total of 611 ischemic stroke patients with serum BDNF measurements from the China Antihypertensive Trial in Acute Ischemic Stroke were included in this analysis. We used the 24-item Hamilton Depression Rating Scale to assess depression status at 3 months after ischemic stroke, and PSD was defined as a score of ≥8. Results Baseline serum BDNF was inversely associated with the risk of depression after ischemic stroke. The multivariable-adjusted odds ratio of PSD for the highest tertile of BDNF was 0.53 (95 % confidence interval, 0.34–0.82; P for trend = 0.004) compared with the lowest tertile. Multivariable-adjusted spline regression model also showed a linear does-response association between serum BDNF levels and PSD at 3 months ( P for linearity = 0.006). In addition, adding serum BDNF to conventional risk factors significantly improved the risk reclassification of PSD (net reclassification improvement: 16.98 %, P = 0.039; integrated discrimination index: 0.93 %, P = 0.026). Limitations All patients in this study were Chinese, so our findings should be applied to other populations cautiously. Conclusions Higher serum BDNF levels at baseline were significantly associated with a decreased risk of PSD at 3 months, suggesting that BDNF might be a valuable predictive biomarker and potential therapeutic target for PSD among ischemic stroke patients.
psychiatry,clinical neurology
What problem does this paper attempt to address?